Zemaira
alpha-1-proteinase inhibitor human · KIT · CSL Behring LLC
Zemaira is an alpha-1-proteinase inhibitor used to treat alpha-1 antitrypsin deficiency, a genetic condition that can damage the lungs and liver. It is administered as directed according to your healthcare provider's instructions.
Key Facts
- Brand Name
- Zemaira
- Generic Name
- alpha-1-proteinase inhibitor human
- NDC Code (Product)
0053-7201- Manufacturer
- CSL Behring LLC
- Dosage Form
- KIT
- Marketing Status
- Application #
- BLA125078
- Marketing Start
- 07/08/2003
Recall History
No Recall HistoryFrequently Asked Questions
What is Zemaira used for?
Zemaira is an alpha-1-proteinase inhibitor used to treat alpha-1 antitrypsin deficiency, a genetic condition that can damage the lungs and liver. It is administered as directed according to your healthcare provider's instructions.
Is Zemaira a controlled substance?
Zemaira is not classified as a controlled substance by the DEA.
What is the generic name for Zemaira?
The generic name for Zemaira is alpha-1-proteinase inhibitor human. There are 3 other brand versions of alpha-1-proteinase inhibitor human.
What is the NDC code for Zemaira ?
The NDC (National Drug Code) for Zemaira is 0053-7201, listed by CSL Behring LLC.